Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl D Atkins

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of the National Cancer Institute|July 20, 2006
Re: Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspectiveCarl D Atkins
Lancet (London, England)|May 15, 2007
Exemestane or tamoxifen?Carl D Atkins
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Overestimation of the prognostic significance of SUV measurement by positron emission tomography for non-small-cell lung cancerCarl D Atkins
Journal of the National Cancer Institute|February 20, 2003
Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinomaCarl D Atkins
JAMA|November 4, 2004
Androgen suppression plus radiation therapy for prostate cancerCarl D Atkins
Journal of the National Cancer Institute|November 4, 2004
Re: Influence of the new AJCC breast cancer staging system on sentinel lymph node positivity and false-negative ratesCarl D Atkins
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2009
CA 19-9 and Lewis antigens in pancreatic cancerCarl D Atkins
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2007
Potential hazards of mammographyCarl D Atkins
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2009
Stopping trials early for positive results: the need to know how muchCarl D Atkins
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2014
Estimating the value of intravenous calcium and magnesium in ameliorating oxaliplatin-induced neuropathyCarl D Atkins
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of the National Cancer Institute|July 20, 2006
Re: Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspectiveCarl D Atkins
Lancet (London, England)|May 15, 2007
Exemestane or tamoxifen?Carl D Atkins
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Overestimation of the prognostic significance of SUV measurement by positron emission tomography for non-small-cell lung cancerCarl D Atkins
Journal of the National Cancer Institute|February 20, 2003
Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinomaCarl D Atkins
JAMA|November 4, 2004
Androgen suppression plus radiation therapy for prostate cancerCarl D Atkins
Journal of the National Cancer Institute|November 4, 2004
Re: Influence of the new AJCC breast cancer staging system on sentinel lymph node positivity and false-negative ratesCarl D Atkins
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2009
CA 19-9 and Lewis antigens in pancreatic cancerCarl D Atkins
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2007
Potential hazards of mammographyCarl D Atkins
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2009
Stopping trials early for positive results: the need to know how muchCarl D Atkins
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2014
Estimating the value of intravenous calcium and magnesium in ameliorating oxaliplatin-induced neuropathyCarl D Atkins
Pageof 3